Literature DB >> 17664068

Synthesis and SAR of p38alpha MAP kinase inhibitors based on heterobicyclic scaffolds.

T G Murali Dhar1, Stephen T Wrobleski, Shuqun Lin, Joseph A Furch, David S Nirschl, Yi Fan, Gordon Todderud, Sidney Pitt, Arthur M Doweyko, John S Sack, Arvind Mathur, Murray McKinnon, Joel C Barrish, John H Dodd, Gary L Schieven, Katerina Leftheris.   

Abstract

The synthesis and structure-activity relationships (SAR) of p38alpha MAP kinase inhibitors based on heterobicyclic scaffolds are described. This effort led to the identification of compound (21) as a potent inhibitor of p38alpha MAP kinase with good cellular potency toward the inhibition of TNF-alpha production. X-ray co-crystallography of an oxalamide analog (24) bound to unphosphorylated p38alpha is also disclosed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17664068     DOI: 10.1016/j.bmcl.2007.07.029

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Synthesis and Evaluation of Pyridinyltriazoles as Inhibitors of p38 MAP Kinase.

Authors:  Seyed Adel Moallem; Farzin Hadizadeh; Fatemeh Abdol Abadi; Mahmoud Shahraki; Jamal Shamsara
Journal:  Iran J Basic Med Sci       Date:  2012-07       Impact factor: 2.699

Review 2.  Kinase inhibitors as potential agents in the treatment of multiple myeloma.

Authors:  Hanley N Abramson
Journal:  Oncotarget       Date:  2016-12-06

3.  Discovery of talmapimod analogues as polypharmacological anti-inflammatory agents.

Authors:  Wandong Liu; Caiyun Hou; Jiaming Li; Xiaodong Ma; Yanchun Zhang; Mengqi Hu; Yuanzheng Huang
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.